Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta interferon in clinical practice]

E Struzziero1, M Corbo

  • 1Divisione di Ostetricia e Ginecologia, Ospedale Generale di Zona, Sacro Cuore di Gesù, Fatebenefratelli-Benevento.

Minerva Ginecologica
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study.

Rhinology·2025
Same author

Universal Prevention of Dementia in Italy: A Document Analysis of the 21 Italian Regional Prevention Plans.

The journal of prevention of Alzheimer's disease·2024
Same author

A novel cell-permeable peptide prevents protein SUMOylation and supports the mislocalization and aggregation of TDP-43.

Neurobiology of disease·2023
Same author

A systematic review on drugs for synaptic plasticity in the treatment of dementia.

Ageing research reviews·2022
Same author

A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

High-precision measurement of the <i>W</i> boson mass with the CDF II detector.

Science (New York, N.Y.)·2022
Same journal

High grade cervical intraepithelial neoplasia positive biopsy: the importance of accurate pre-operative workup.

Minerva ginecologica·2021
Same journal

Efficacy and safety of a novel vaginal medical device in recurrent bacterial vaginosis: a multicenter clinical trial.

Minerva ginecologica·2020
Same journal

[Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome].

Minerva ginecologica·2020
Same journal

Update on new imaging technologies in sentinel node detection.

Minerva ginecologica·2020
Same journal

Postoperative pelvic dysfunctions associated with the reconstruction of the pelvic floor.

Minerva ginecologica·2020
Same journal

The role of sentinel-node biopsy in ovarian cancer.

Minerva ginecologica·2020
See all related articles

Intramuscular interferon beta effectively treats moderate dysplasia linked to Human Papillomavirus (HPV) infection. Treatment promotes significant viral regression, outperforming spontaneous recovery.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Cervical dysplasia is often associated with Human Papillomavirus (HPV) infection.
  • Moderate dysplasia requires effective therapeutic interventions to prevent progression.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of intramuscular interferon beta in patients with moderate dysplasia and HPV infection.
  • To assess the impact of treatment on viral load and lesion regression.

Main Methods:

  • Patients with moderate dysplasia and confirmed HPV infection received intramuscular interferon beta.
  • Viral regression and lesion status were monitored throughout the treatment period.

Main Results:

  • Intramuscular interferon beta demonstrated a positive therapeutic effect on moderate dysplasia.

Related Experiment Videos

  • The treatment led to significant progressive viral regression, exceeding spontaneous regression rates.
  • A satisfactory clinical response was observed in patients treated with interferon beta.

    • Conclusions:

    • Intramuscular interferon beta is an effective treatment for moderate dysplasia associated with HPV infection.
    • The therapy promotes substantial viral clearance and lesion regression.
    • Interferon beta offers a superior alternative to spontaneous regression for managing HPV-related dysplasia.